GPR55 and influenza: Drugs triggering GPR55 upregulation in the immune cells were identified, namely tofacitinib (immunosuppressant acting as janus kinase inhibitor), canakinumab (anti-inflammatory monoclonal antibody targeting interleukin-1β), and an influenza vaccine.